ArticleScientific reports2026
An explainable AI-driven hybrid feature selection approach for coronary artery disease diagnosis.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A comparative study of quantum-inspired PSO and EA with their binary variants for heart disease classification.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Coronary artery disease (CAD), where the heart does not get enough oxygen-rich blood due to a buildup of fatty matter, is a leading cause of death worldwide. Since its symptoms may not be recognized until a cardiac attack occurs, its early diagnosis is crucial. In this paper, we introduce the SHAP Optimized Wrapper (SHOW) feature selection algorithm, which works in two steps. First, a SHapley Additive exPlanations (SHAP) method is developed using XGBoost, Random Forest (RF), and Support Vector Machine (SVM) classifiers, to rank the features based on their diagnostic significance. Second, an optimized sequential forward selection wrapper technique is employed, whereby the ranked features are evaluated to select the optimal subset. To validate the algorithm, it is used in seven classifiers to classify three public domain CAD data sets. The classifiers are XGBoost, RF, SVM, Decision Tree (DT), Logistic Regression (LR), K-Nearest Neighbors (KNN), and Multilayer Perceptron (MLP). The data sets are the Z-Alizadeh Sani, Cleveland, and Statlog. Leveraging stratified 10-fold cross-validation and delicate hyperparameter tuning, the results reveal that the SHOW algorithm significantly outperforms 14 state-of-the-art competitive algorithms in terms of accuracy and the number of selected features, while also demonstrating favorable performance in clinically relevant metrics such as sensitivity, specificity, AUC, and F1-score. For example, using the XGBoost classifier, the algorithm selects 14 features (out of 55) from the Z-Alizadeh Sani data set, achieving 93.79% accuracy, 93.98% sensitivity, 89.81% specificity, 0.97 AUC, and 93.98% F1-score; 5 features (out of 13) from the Cleveland data set, achieving 86.52% accuracy, 88.55% sensitivity, 85% specificity, 0.89 AUC, and 84.84% F1-score; and 5 features (out of 13) from the Statlog data set, achieving 87.78% accuracy, 80% sensitivity, 92.67% specificity, 0.90 AUC, and 85.18% F1-score. These figures are not matched by any of the 14 competitive algorithms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.